Intrahepatic cholangiocarcinoma: A single-cell resolution unraveling the complexity of the tumor microenvironment

Luca Fabris¹, Jesper B Andersen², Laura Fouassier³

Affiliations

¹ Department of Molecular Medicine, General Medicine Division, University-Hospital of Padua, Padua, Italy; Liver Center and Section of Digestive Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT.
² Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
³ Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine (CRSA), UMRS 928, F-75012 Paris, France. Electronic address: laura.fouassier@inserm.fr.

PMID: 32900521
DOI: 10.1016/j.jhep.2020.07.017

Free article

Editorial

Intrahepatic cholangiocarcinoma: A single-cell resolution unraveling the complexity of the tumor microenvironment

Luca Fabris et al. J Hepatol. 2020 Nov.

Free article

. 2020 Nov;73(5):1007-1009.

doi: 10.1016/j.jhep.2020.07.017. Epub 2020 Sep 6.

Authors

Luca Fabris¹, Jesper B Andersen², Laura Fouassier³

Affiliations

¹ Department of Molecular Medicine, General Medicine Division, University-Hospital of Padua, Padua, Italy; Liver Center and Section of Digestive Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT.
² Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
³ Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine (CRSA), UMRS 928, F-75012 Paris, France. Electronic address: laura.fouassier@inserm.fr.

PMID: 32900521
DOI: 10.1016/j.jhep.2020.07.017

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest The authors declare no conflicts of interest that pertain to this work. Please refer to the accompanying ICMJE disclosure forms for further details.

Comment on

Single-cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma.
Zhang M, Yang H, Wan L, Wang Z, Wang H, Ge C, Liu Y, Hao Y, Zhang D, Shi G, Gong Y, Ni Y, Wang C, Zhang Y, Xi J, Wang S, Shi L, Zhang L, Yue W, Pei X, Liu B, Yan X. Zhang M, et al. J Hepatol. 2020 Nov;73(5):1118-1130. doi: 10.1016/j.jhep.2020.05.039. Epub 2020 Jun 5. J Hepatol. 2020. PMID: 32505533

Cited by

ESR1 as a recurrence-related gene in intrahepatic cholangiocarcinoma: a weighted gene coexpression network analysis.
Li F, Chen Q, Yang Y, Li M, Zhang L, Yan Z, Zhang J, Wang K. Li F, et al. Cancer Cell Int. 2021 Apr 17;21(1):225. doi: 10.1186/s12935-021-01929-5. Cancer Cell Int. 2021. PMID: 33865377 Free PMC article.
Macro CD5L⁺ deteriorates CD8⁺T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinoma.
Lu JC, Wu LL, Sun YN, Huang XY, Gao C, Guo XJ, Zeng HY, Qu XD, Chen Y, Wu D, Pei YZ, Meng XL, Zheng YM, Liang C, Zhang PF, Cai JB, Ding ZB, Yang GH, Ren N, Huang C, Wang XY, Gao Q, Sun QM, Shi YH, Qiu SJ, Ke AW, Shi GM, Zhou J, Sun YD, Fan J. Lu JC, et al. Nat Commun. 2024 Jan 20;15(1):621. doi: 10.1038/s41467-024-44795-1. Nat Commun. 2024. PMID: 38245530 Free PMC article.
The Transmembrane Receptor TIRC7 Identifies a Distinct Subset of Immune Cells with Prognostic Implications in Cholangiocarcinoma.
Albrecht T, Goeppert B, Brinkmann F, Charbel A, Zhang Q, Schreck J, Wilhelm N, Singer S, Köhler BC, Springfeld C, Mehrabi A, Schirmacher P, Kühl AA, Vogel MN, Jansen H, Utku N, Roessler S. Albrecht T, et al. Cancers (Basel). 2021 Dec 14;13(24):6272. doi: 10.3390/cancers13246272. Cancers (Basel). 2021. PMID: 34944891 Free PMC article.
NUF2 Drives Cholangiocarcinoma Progression and Migration via Inhibiting Autophagic Degradation of TFR1.
Shan J, Jiang W, Chang J, Zhou T, Chen Y, Zhang Y, Wang J, Wang Y, Wang Y, Xu X, Liu S, Shi X, Fan S, Chen R, Li C, Li X. Shan J, et al. Int J Biol Sci. 2023 Feb 21;19(5):1336-1351. doi: 10.7150/ijbs.80737. eCollection 2023. Int J Biol Sci. 2023. PMID: 37056930 Free PMC article.
Translating imaging traits of mass-forming intrahepatic cholangiocarcinoma into the clinic: From prognostic to therapeutic insights.
Ji GW, Xu Q, Jiao CY, Lu M, Xu ZG, Zhang B, Yang Y, Wang K, Li XC, Wang XH. Ji GW, et al. JHEP Rep. 2023 Jul 4;5(10):100839. doi: 10.1016/j.jhepr.2023.100839. eCollection 2023 Oct. JHEP Rep. 2023. PMID: 37663120 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Intrahepatic cholangiocarcinoma: A single-cell resolution unraveling the complexity of the tumor microenvironment

Affiliations

Intrahepatic cholangiocarcinoma: A single-cell resolution unraveling the complexity of the tumor microenvironment

Authors

Affiliations

Conflict of interest statement

Comment on

Similar articles

Cited by

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical